Catalent launches accelerated gene-to-drug substance program for complex molecules in U.S.
CTLT•Catalent launched an accelerated gene-to-drug substance program for complex molecules in the U.S.
1. Program launch
Catalent launched an accelerated gene-to-drug substance program for complex molecules in the U.S.
